Clinical Trial Update: Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Cirtuvivint in selected advanced soft tissue sarcomas is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Cirtuvivint

Snippet

Sponsor: Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas | Conditions: Soft Tissue Sarcoma (STS) | Phase 2 | Status: RECRUITING